Vienna, Austria

Margit Weghofer

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Margit Weghofer: Innovator in Allergy and Vaccine Research

Introduction

Margit Weghofer is a notable inventor based in Vienna, Austria. She has made significant contributions to the fields of allergy research and vaccine development. With a total of 3 patents to her name, her work has had a meaningful impact on medical science.

Latest Patents

Weghofer's latest patents include innovative solutions for allergy treatment and vaccine development. One of her patents focuses on a house dust mite allergen, which involves an immobilized polypeptide bound to a surface of a polypeptide array or chip. This polypeptide has specific amino acid sequences that are crucial for its function. Another significant patent is an anti-HER2 vaccine based on AAV-derived multimeric structures. This invention relates to parvovirus mutated structural proteins that include insertions of mimotopes of HER2, along with various compositions, medicaments, and methods for inducing a B-cell response or treating HER2-related diseases.

Career Highlights

Throughout her career, Margit Weghofer has worked with prominent companies such as Biomay AG and Medigene AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the biotechnology sector.

Collaborations

Weghofer has collaborated with esteemed colleagues, including Rudolf Valenta and Susanne Vrtala. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Margit Weghofer's contributions to allergy and vaccine research highlight her role as a leading inventor in her field. Her innovative patents and collaborations continue to influence medical science and improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…